Atara Biotherapeutics, Inc.
Pioneering off-the-shelf allogeneic T-cell immunotherapies for cancer and autoimmune diseases.
ATRA | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 1280 RANCHO CONEJO BLVD, 91320 THOUSAND OAKS
- Website:
- https://www.atarabio.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Atara Biotherapeutics, Inc. is a pioneer in allogeneic T-cell immunotherapy, developing transformative, off-the-shelf therapies for patients with cancer and autoimmune diseases. The company harnesses the natural biology of T cells through a versatile platform that enables scalable manufacturing and rapid delivery of treatments from inventory. Atara is distinguished as the first company to receive regulatory approval for an allogeneic T-cell immunotherapy. Its pipeline focuses on applying this technology, including novel chimeric antigen receptor (CAR) T-cell therapies, to address a wide range of difficult-to-treat conditions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Atara Biotherapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Atara Biotherapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Atara Biotherapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
